Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
09/2002
09/11/2002EP1237887A1 9-(piperazinylalkyl)carbazoles as bax-modulators
09/11/2002EP1237875A1 Substituted imidazole neuropeptide y y5 receptor antagonists
09/11/2002EP1237874A2 Selective neurokinin antagonists
09/11/2002EP1237865A1 A factory scale process for producing crystalline atorvastatin trihydrate hemi calcium salt
09/11/2002EP1237862A1 Succinate compounds, compositions and methods of use and preparation
09/11/2002EP1237849A1 Activators of soluble guanylate cyclase
09/11/2002EP0934309B1 New pyridyl alkane acid amides as cytostatics and immunosuppressives
09/11/2002EP0799206B1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
09/11/2002EP0668860B1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses
09/11/2002CN1368969A Indolylpiperidine derivatives as antihistaminic and antiallergic agents
09/11/2002CN1368958A Arylsulfonamido-substituted hydroxamic acid derivatives
09/11/2002CN1090629C Novel Heterocyclic compounds
09/11/2002CN1090628C New N-aryl piperidine compounds, process for their preparation and pharmaceutical compositions containing them
09/11/2002CN1090627C 2-amino-1,2-indene compounds, process for their preparation and pharmaceutical compositions containing them
09/11/2002CN1090624C Herbicidalor fungicidal sulphonylaminocarbonyltria with hologenated alk(en) oxy substitutuents
09/11/2002CN1090623C 3-aryl-1,2,4-triazole derivatives with herbicidal properties
09/11/2002CN1090617C Pyrole derivatives and medicinal composition
09/10/2002US6448407 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis
09/10/2002US6448403 Dehalogenation and amination to synthesize such as 4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)amino)-2-cyclopentene-1 -methanol; chemical intermediates for purine nucleoside analogues
09/10/2002US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors
09/10/2002US6448281 Inhibitors of hepatitis c virus replication; treatment of hepatitis c
09/10/2002US6448277 VEGF receptor tyrosine kinase inhibitors
09/10/2002US6448270 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
09/10/2002US6448269 Such as 6-(n-(4-(aminoiminomethyl)benzoyl)amino)-3,4-dihydro-4,4-dimethyl-2h-1 -benzopyran-2-yl)acetic acid; inhibiting platelet aggregation or fibrinogen binding or preventing thrombosis
09/10/2002US6448260 Endothelin receptor antagonists
09/10/2002US6448259 Cycloalkyl-4-oxonicotinic carboxamides; agonists, antagonists or inverse agonists for gamma aminobutyric acid binding site, the benzodiazepine receptor; anxiety, sleep and seizure disorders sedative, anxiolytic and anticonvulsant activity
09/10/2002US6448250 Sulfamato hydroxamic acid metalloprotease inhibitor
09/10/2002US6448244 Broad-spectrum antifungals, against which there is no existing resistance and which can be administered intravenously or transungually
09/10/2002US6448243 Serotonin antagonist for treating, ameliorating and preventing spastic paralysis or central muscle relaxants for ameliorating myotonia
09/10/2002US6448205 For the desiccation and/or defoliation of plants
09/10/2002US6448203 Substituted aryluracils
09/10/2002US6447998 Method of detecting the presence, absence or amount of a particular dna duplex in a sample suspected of containing dna comprising contacting the sample with an oligomer of under conditions wherein a triple helix is formed between the
09/10/2002US6447644 Inhibition of pulp and paper yellowing using nitroxides, hydroxylamines and other coadditives
09/06/2002WO2002068424A1 Indole derivatives having an inhibitory effect on protein kinases
09/06/2002WO2002068417A2 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
09/06/2002WO2002068416A2 Process of preparing paroxetine and intermediates for use therein
09/06/2002WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors
09/06/2002WO2002068410A1 Substituted pyrimidinone derivatives as ligands of integrin receptors
09/06/2002WO2002068406A2 Substituted amine derivatives and their use for the treatment of angiogenesis
09/06/2002WO2002068404A1 Method for producing optically active dihydropyrones
09/06/2002WO2002068397A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors
09/06/2002WO2002068393A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
09/06/2002WO2002068057A1 Barbiturates as integrin antagonists and their use for treating inflammatory diseases
09/06/2002WO2002067939A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
09/06/2002WO2002067684A1 Pyridyl pyrimidines for use as pesticides
09/06/2002WO2002067675A2 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides
09/06/2002WO2002046183A3 Indazolyl-substituted pyrroline compounds as kinase inhibitors
09/06/2002WO2002032868A3 2-substituted heterocyclic compounds and their use in treating multidrug resistance
09/06/2002WO2002022577A3 Hydroxamate derivatives useful as deacetylase inhibitors
09/06/2002WO2002008475A3 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
09/06/2002CA2439463A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors
09/06/2002CA2439265A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
09/06/2002CA2438892A1 Process of preparing paroxetine and intermediates for use therein
09/06/2002CA2434666A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
09/06/2002CA2424768A1 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides
09/05/2002US20020123634 Asymmetric derivatives of furamidines; contacting the sample DNA with above compound
09/05/2002US20020123527 Administering a 2-hydroxy-4-oxo- or 4,6-dioxo-6-pheny-l or naphthyl- hex-2-enoic acid; viricides; AIDS/ARC
09/05/2002US20020123510 Administering an NR2B subtype selective N-methyl-D-aspartate (NMDA) receptor antagonist with a thrombolytic agent for treating hypoxic or ischemic stroke
09/05/2002US20020123506 7-Heterocyclyl quinoline and thieno(2,3-b)pyridine derivatives useful as antagonists of gonadotropin releasing hormone
09/05/2002US20020123498 For inhibiting transport protein; therapy
09/05/2002US20020123494 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death
09/05/2002US20020123032 Detection of disease related genes
09/05/2002DE10109867A1 Verwendung von Triazolverbindungen zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie Use of triazole compounds for the prophylaxis and treatment of neurodegenerative diseases, brain trauma and cerebral ischemia
09/05/2002DE10109807A1 Verbrückte Diaminopyrazole und diese Verbindungen enthaltende Färbemittel Bridged diaminopyrazoles and colorants containing these compounds
09/05/2002DE10109280A1 Indolderivate mit inhibitorischer Wirkung auf Proteinkinasen Indole derivatives having an inhibitory effect on protein kinases
09/05/2002DE10108470A1 Verfahren zur Herstellung optisch aktiver Dihydropyrone A process for preparing optically active dihydropyrones
09/04/2002EP1236723A1 Sulfamide derivatives useful as beta3 agonists and pharmaceutical uses thereof
09/04/2002EP1236719A1 Novel heterocyclic compounds and salts thereof and medicinal use of the same
09/04/2002EP1236460A1 Bridged diamino pyrazoles and colouring agents containing them
09/04/2002EP1235809A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments
09/04/2002EP1235803A1 Urea compounds having muscarinic receptor antagonist activity
09/04/2002EP1235802A1 Carbamate derivatives having muscarinic receptor antagonist activity
09/04/2002EP1235618A2 Bioconjugation in vivo to pulmonary or blood components
09/04/2002EP1235572A2 Method to treat pain utilizing benzimidazole nmda/nr2b antagonists
09/04/2002EP1068184B1 N-aryloxyethylamine derivatives for the treatment of depression
09/04/2002EP1037888B1 (e)-3-[1-n-butyl- 5-[2-(2-carboxyphenyl)methoxy- 4-chlorophenyl]-1h- pyrazol-4-yl]-2- [(5- methoxy-2,3- dihydrobenzofuran-6-yl)methyl]- prop-2-enoic acid monoargininyl salt
09/04/2002EP0966444B1 Process for preparing pyrazole derivatives
09/04/2002EP0858459B1 Novel acid pyrazole derivatives, preparation method therefor, use thereof as drugs, novel use therefor, and pharmaceutical compositions containing such derivatives
09/04/2002EP0642506B1 Heterocyclically bisubstituted sulphonyl amino(thio)carbonyl compounds
09/04/2002CN1367784A Novel process for preparation of substituted propenone derivatives
09/04/2002CN1367778A Novel carboxylic acid derivatives with 5,6 substitutedpyrimidine ring, their production and utilization thereof as endothelin receptor antagonists
09/04/2002CN1367678A Method of treating hair loss using ketoamides
09/04/2002CN1367169A Substituted 6,6-Hetero-dicycloderivative
09/04/2002CN1090187C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS
09/04/2002CN1090186C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS
09/04/2002CN1090183C Sulphonylaminocarbonyltriazolinones with halogenated alk(EN)ylthio substituents
09/03/2002US6444829 (2s,4r)-4-mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid n'-isobutyl-n'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators
09/03/2002US6444823 Pyridyl alkane acid amides as cytostatics and immunosuppressives
09/03/2002US6444822 Antidepressants
09/03/2002US6444820 Process for the manufacture of camptothecin derivatives
09/03/2002US6444814 Reacting epichlorohydrin and isocyanuric acid
09/03/2002US6444811 Central nervous system disorders; cardiovascular disorders
09/03/2002US6444696 1-aryl or heteroaryl substituted 5-amino-4 carbonylpyrazole derivatives; antiinflammatory agents
09/03/2002US6444694 Styryl benzimidazole derivatives
09/03/2002US6444687 Eating disorders and diabetes
09/03/2002US6444686 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
09/03/2002US6444679 Neurological and gastrointestinal disorders; delta opioid ligands or opioid receptors
09/03/2002US6444672 Heterocyclic derivatives and their use as antithrombotic agents
09/03/2002US6444612 Use of 5-amino-pyrazol-derivatives for combating micro-organisms
09/01/2002CA2373578A1 .beta.3, agonists and uses thereof